生物可用的丸激素降低了肺状细胞癌的风险:一项全面的数据研究
Jihang Luo1, Puyu Liu2, Jian Song3
1Department of Infectious Diseases, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Journal of translational medicine
|December 30, 2025
概括
较高的生物可利用水平 (BTLs) 可能会降低肺状细胞癌 (LUSC) 的风险. 雄激素受体表达与更好的LUSC预后有关,这表明了诊断和治疗的潜在生物标志物.
科学领域:
- 内分泌学和瘤学的内分泌学和瘤学.
- 遗传流行病学遗传流行病学
背景情况:
- 丸激素和肺癌之间的关系尚未得到充分证实.
- 这项研究检查了生物可用水平 (BTLs),总水平 (TTLs) 和性激素结合型全球蛋白 (SHBG) 与肺癌风险和亚型的关系.
研究的目的:
- 调查丸激素水平与肺癌风险之间的因果关系.
- 探索生物可用和雄激素受体 (AR) 表达在肺状细胞癌 (LUSC) 预后中的作用.
主要方法:
- 使用全基因组关联研究 (GWAS) 数据进行双向和多变量门德尔随机化 (MR) 分析.
- 在90名LUSC患者的队列中进行AR表达和生存分析的免疫组织化学 (IHC) 染色.
主要成果:
- 较高的BTL与较低的LUSC风险显著相关 (OR=0.365,P=0.001).
- 在TTL或SHBG和LUSC风险之间没有发现显著的关联.
- 在LUSC患者中,AR表达与改善的无进展和整体存活率相关,并且是独立的保护因素.
结论:
- 升高的BTL可能会提供对LUSC发展的保护.
- BTLs和AR表达显示为LUSC.的诊断和预后生物标志物具有前途.
相关概念视频
01:26Testosterone: Functions and Regulation
1.9K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
1.9K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K